Correction to “Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real‐World Effectiveness and Safety From a Prospective Cohort”
2026
Read Correction to “Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real‐World Effectiveness and Safety From a Prospective Cohort” (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13631381.txt.
Description
The authors of a 2026 study of dual targeted therapy for hard-to-treat psoriatic arthritis issued this correction. One results table had been calculated from an early analysis including patients with incomplete follow-up, against the study's own methods. All values were recomputed using complete cases only. Two physician-rated measures were dropped, as too few patients had full data. Two skin measures were added in their place. One results passage was rewritten to show joint swelling eased later than first stated. The abstract, safety findings, and conclusions are unchanged.
Catalog record
| YEAR | 2026 |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |